Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in OABI — OmniAb, Inc.

CIK 1390777 NEW YORK, NY
Back to OABI Full portfolio

Position in OABI

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$783,277
+$352,390 QoQ
Shares Held
318,406
+16.0% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 143 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in OABI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,654 across 311 Biotechnology names. OABI ranks #212 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in OABI

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $783,277 318,406
2026-03-31 $430,887 274,451
2025-12-31 $496,991 268,645
2025-09-30 $421,915 263,698
2025-06-30 $471,104 270,751
2025-03-31 $619,540 258,142
2024-12-31 $917,463 259,171
2024-09-30 $1,362,981 322,218
2024-06-30 $1,488,610 396,963
2024-03-31 $2,293,574 423,169
2023-12-31 $2,868,765 464,954
2023-09-30 $2,171,695 418,439
2023-06-30 $2,054,853 408,520
2023-03-31 $1,341,439 364,522
2022-12-31 $1,345,309 373,698